Latest / The CEO Diary with Fexingo: Leadership Lessons, Executive Decisions, and Corner Office Stories
How Novo Nordisk Conquered Obesity and the Weight Loss Drug Market
In this episode, Lucas and Luna dive into the story of Novo Nordisk, the Danish pharmaceutical giant that has become the world's most valuable company in Europe by dominating the weight loss drug market with Ozempic and Wegovy. They explore how CEO Lars Fruergaard Jørgensen navigated supply shortages, regulatory hurdles, and public scrutiny, while maintaining a purpose-driven culture. The hosts discuss the company's unconventional origins as a insulin maker, its shift into GLP-1 drugs, and the strategic decisions that led to a market cap exceeding $600 billion. Along the way, they…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.